Please contact your
local representative or



An ideal combination of passive and active components

The Orsiro Hybrid Drug Eluting Stent brings the optimal combination of effortless deliverability, coupled with a hybrid coating for treating coronary artery stenosis.

This unique concept opens a new generation of drug eluting stents for improving patient outcomes.

The highly deliverable Orsiro stent is now available in lengths up to 40 mm to address a wider range of lesions.






PrintPrint Page MailE-Mail Page Text Size